Respiratory medicineHumansExosomesCOVID-19MaleFemale
Therapeutic potential of hUCMSC-derived exosomes in modulating inflammation and immune response in COVID-19-associated ARDS: A randomized clinical trial.
Mofid Hosseinzadeh, Mandana Pouladzadeh, Reza Khedri, Seyed Yashar Oskouei, Payam Amini, Mehrdad Dargahi-Malamir, Naser Kamyari, Hooshmand Hosseininejad, Seyed Saeed Seyedian, Alireza Shoae-Hassani, Atefeh Akbari Motlagh, Azam Hadipour, Hossein Hamidi, Ali Saeedi-Boroujeni, Mohammad Reza Mahmoudian-Sani
Published: 202510.1016/j.rmed.2025.108475
Abstract
INTRODUCTION: COVID-19 has become a global pandemic, potentially leading to conditions like ARDS. The infection triggers severe inflammation and cytokine storms, damaging the lungs and other organs. MSCs and their derived exosomes are suggested as th…
Preview only. Read the full abstract at the source